Muscular Dystrophy Association

104 articles about Muscular Dystrophy Association

• The ALS Association And Muscular Dystrophy Association Team Up To Advance ALS Therapy Concept

  12/4/2014

• Muscular Dystrophy Association Awards Second "Bridge-To-Industry" Grant

  12/12/2013

• Quintiles, Inc. Selected by Muscular Dystrophy Association to Develop U.S. Disease Registry

  10/8/2013

• NicOx SA Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference

  4/24/2013

• Muscular Dystrophy Association: Scientific Conference to Focus on Therapy Development for Neuromuscular Diseases

  4/22/2013

• Fate Therapeutics Presents Preclinical Efficacy Data for WNT7A-Analog Program at Muscular Dystrophy Association 2013 Scientific Conference

  4/22/2013

• StorageMart: Pinterest Campaign Supports Research for Spinal Muscular Atrophy

  3/19/2013

• Muscular Dystrophy Association Release: Drug for Duchenne Muscular Dystrophy Successfully Completes Phase 1 Trial; Trial in Boys With DMD May be Next

  10/11/2012

• Muscular Dystrophy Association Board Appoints Steven M. Derks President and Chief Executive Officer

  9/18/2012

• U.S. Patent Office Issues Sixth Patent Covering "Zero-Footprint" Medical Image Viewers to Heart Imaging Technologies, LLC

  5/1/2012

• Muscular Dystrophy Association Release: SMT C1100 for Duchenne Muscular Dystrophy Moves to Human Testing

  4/24/2012

• Lowe's Raises More Than $7.6 Million for Muscular Dystrophy Association's Shamrocks Against Dystrophy

  4/5/2012

• Muscular Dystrophy Association Awards $120,000 to Catabasis Pharmaceuticals, Inc.

  4/4/2012

• Muscular Dystrophy Association Awards More Than $12 Million in Grants to Advance Neuromuscular Disease Research

  2/2/2012

• Muscular Dystrophy Association Awards $1 Million to Tivorsan Pharmaceuticals, Inc. for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment

  1/5/2012

• Muscular Dystrophy Association Awards $750,000 to Help Summit Test New Drug Formulation in Phase 1 Clinical Trial of Potential Treatment for Duchenne Muscular Dystrophy

  12/19/2011

• 6th Annual Muscular Dystrophy Association Tradition of Hope Gala Goal: $500,000+ for ALS Research

  10/5/2011

• Muscular Dystrophy Association Primetime Telethon Achieves $61.5 Million

  9/6/2011

• Muscular Dystrophy Association Awards $13.7 Million for 40 New Research Grants

  8/24/2011

• Muscular Dystrophy Association Collaborates with AVI BioPharma, Inc. on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy

  8/16/2011